Journal
CHEMISTRY-A EUROPEAN JOURNAL
Volume 18, Issue 45, Pages 14464-14472Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/chem.201202171
Keywords
cytotoxicity; dithiocarbamates; lung cancer; ruthenium; S ligands
Categories
Funding
- Department of Chemical Sciences of the University of Padova
- PRAT
Ask authors/readers for more resources
Hereby we present the synthesis of several ruthenium(II) and ruthenium(III) dithiocarbamato complexes. Proceeding from the Na[trans-RuIII(dmso)2Cl4] (2) and cis-[RuII(dmso)4Cl2] (3) precursors, the diamagnetic, mixed-ligand [RuIIL2(dmso)2] complexes 4 and 5, the paramagnetic, neutral [RuIIIL3] monomers 6 and 7, the antiferromagnetically coupled ionic a-[RuIII2L5]Cl complexes 8 and 9 as well as the beta-[RuIII2L5]Cl dinuclear species 10 and 11 (L=dimethyl- (DMDT) and pyrrolidinedithiocarbamate (PDT)) were obtained. All the compounds were fully characterised by elemental analysis as well as 1H NMR and FTIR spectroscopy. Moreover, for the first time the crystal structures of the dinuclear beta-[RuIII2(dmdt)5]BF4 center dot CHCl3 center dot CH3CN and of the novel [RuIIL2(dmso)2] complexes were also determined and discussed. For both the mono- and dinuclear RuII and RuIII complexes the central metal atoms assume a distorted octahedral geometry. Furthermore, in vitro cytotoxicity of the complexes has been evaluated on non-small-cell lung cancer (NSCLC) NCI-H1975 cells. All the mono- and dinuclear RuIII dithiocarbamato compounds (i.e., complexes 610) show interesting cytotoxic activity, up to one order of magnitude higher with respect to cisplatin. Otherwise, no significant antiproliferative effect for either the precursors 2 and 3 or the RuII complexes 4 and 5 has been observed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available